TSND-201 for the Treatment for PTSD: Improvement in Sleep-Related Outcomes from the Open-label Portion of the IMPACT-1 Study (W45)

Summary of poster presentation: Participants treated with TSND-201 had a positive impact on sleep. TSND-201 showed improvements on the sleep-specific items of the Clinician Administered PTSD Scale for PTSD (CAPS-5), in addition to the total severity score. Similarly, improvements on the sleep item of the Montgomery-Asberg Depression Rating Scale (MADRS) were improved after treatment with TSND-201. Improvements in sleep were also consistently improved on the Pittsburgh Sleep Quality Index (PSQI), a general measure of overall sleep. View Poster

The release as fetched from its publisher. transcendtherapeutics.com ↗